Work

Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.

Year: 2000

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: P B Chapman, D M Morrissey, K S Panageas, W B Hamilton, C Zhan, A N Destro, L Williams, R J Israel, P O Livingston

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Targeted antigen receptor treatment of cancer

OpenAlex ID: W2121229568

FWCI: 1.768

Cites: 8

Cited by: 102

Related to: 10